Ruiwen Ruan

机构：Nanchang University, First Affiliated Hospital of Jiangxi Medical College, Jiangxi Provincial Cancer Hospital, First Affiliated Hospital of Nanchang University

发表论文 17 篇 · 总被引 294 次 · h-index 7

代表论文

• Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment (2023 · Molecular Cancer · 被引 120)
• Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion (2025 · Cell Communication and Signaling · 被引 49)
• Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer (2023 · Frontiers in Immunology · 被引 33)
• Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer (2024 · Journal of Translational Medicine · 被引 25)
• TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer (2024 · Cell Communication and Signaling · 被引 21)
• MDM2 inhibitors in cancer immunotherapy: Current status and perspective (2024 · Genes & Diseases · 被引 17)